Artiva Biotherapeutics, Inc.ARTVNASDAQ
LOADING
|||
EV to Sales: Premium Valuation
Trending higher, above historical average.
Left:
||||
Enterprise value to sales ratio
Latest
875.30
↑ 462% above average
Average (5y)
155.73
Historical baseline
Range
High:875.30
Low:0.00
Volatility
562.1%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 875.30 | +11974.6% |
| 2023 | 7.25 | -72.1% |
| 2022 | 25.94 | +0.2% |
| 2021 | 25.88 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |